Hepatitis/Infectious disease Seminar
Infectious diseases, cancer and treatment of hepatitis – from a drug discovery perspective
Oplysninger om arrangementet
Tidspunkt
Sted
Jeppe Vontillius auditoriet, Aarhus Universitet, Bygning 1252 - Bartholins Allé 3, 8000 Aarhus C
MSD Denmark and Merck Research Labs will host a seminar focusing on these topics.
The talks will be given by Todd Black, Ernest Asante-Appiah, and Rohit Talwani from Merck Research
labs in the US. They have all played a central role in the development of the treatment of Hepatitis C
for Merck/MSD.
HOW:
Just show up
MORE:
Lunch included hosted by MSD Denmark
AGENDA:
- 13-13:45
Overview of current MSD anti-infectives; research activities within hepatitis, anti-bacterial and anti-fungal treatments.
Todd Black, Exec. Dir., Biology – Discovery, Infectious Diseases - 13:45-14:15 Lunch
- 14:15-15:00
Development of compounds from a Merck perspective – from idea to testing of the drug, with focus on the methods, analysis, technics and pathways explored
Ernest Asante-Appiah, Dir., Biology – Discovery, Infectious Diseases - 15:00-15:45
HCV and cancer – HCC and beyond
Rohit Talwani, Dir., Clinical Research – Late Stage HCV, Infectious Diseases - 15:45-16 Open discussion
Sincerely
Bent Deleuran
Institute of Biomedicine, Aarhus University
bd@biomed.au.dk
Trine Kallehave
MSD Denmark
trine.kallehave@merck.com